Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$578M |
| 2 |
Micron Technology
MU
|
+$433M |
| 3 |
Advanced Micro Devices
AMD
|
+$404M |
| 4 |
Amazon
AMZN
|
+$398M |
| 5 |
Accenture
ACN
|
+$358M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$777M |
| 2 |
Meta Platforms (Facebook)
META
|
+$752M |
| 3 |
Tesla
TSLA
|
+$627M |
| 4 |
Chevron
CVX
|
+$528M |
| 5 |
Shopify
SHOP
|
+$439M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.46% |
| 2 | Technology | 18.58% |
| 3 | Consumer Staples | 10.15% |
| 4 | Consumer Discretionary | 9.72% |
| 5 | Financials | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Invesco S&P Emerging Markets Low Volatility ETF
EELV
$422M
| $422K | ﹤0.01% |
+20,100
| New | +$461K |
|
3027
BioXcel Therapeutics
BTAI
$35.2M
| $420K | ﹤0.01% |
2,219
-1,256
| -36% | -$292K |
|
|
WCLD
3028
WisdomTree Cloud Computing Fund
WCLD
$312M
| $419K | ﹤0.01% |
15,700
-16,710
| -52% | -$500K |
|
3029
HireQuest
HQI
$238M
| $418K | ﹤0.01% |
32,400
-6,400
| -16% | -$91.1K |
|
3030
Genesco
GCO
$390M
| $417K | ﹤0.01% |
10,600
-4,800
| -31% | -$256K |
|
|
MITT
3031
TPG Mortgage Investment Trust
MITT
$214M
| $417K | ﹤0.01% |
101,400
-123,800
| -55% | -$829K |
|
3032
Urban Outfitters
URBN
$6.69B
| $417K | ﹤0.01% |
+21,200
| New | +$444K |
|
3033
Ebang International Holdings
EBON
$12.7M
| $416K | ﹤0.01% |
33,837
+5,284
| +19% | +$78.1K |
|
|
INZY
3034
DELISTED
Inozyme Pharma
INZY
| $416K | ﹤0.01% |
155,400
+37,100
| +31% | +$134K |
|
3035
iShares Russell Mid-Cap ETF
IWR
$58.4B
| $416K | ﹤0.01% |
6,700
-12,600
| -65% | -$867K |
|
|
IRD
3036
Opus Genetics
IRD
$300M
| $416K | ﹤0.01% |
206,901
+8,711
| +4% | +$18.8K |
|
|
DOMA
3037
DELISTED
Doma Holdings, Inc.
DOMA
| $415K | ﹤0.01% |
37,748
+5,872
| +18% | +$105K |
|
3038
WisdomTree US SmallCap Dividend Fund
DES
$2.24B
| $414K | ﹤0.01% |
+16,100
| New | +$467K |
|
3039
VSE Corp
VSEC
$6.74B
| $414K | ﹤0.01% |
11,700
-3,500
| -23% | -$136K |
|
3040
X4 Pharmaceuticals
XFOR
$417M
| $414K | ﹤0.01% |
8,073
+867
| +12% | +$30K |
|
|
QUMU
3041
DELISTED
Qumu Corp.
QUMU
| $414K | ﹤0.01% |
678,856
-39,200
| -5% | -$28.4K |
|
3042
Immunic
IMUX
$220M
| $413K | ﹤0.01% |
13,067
+10,147
| +348% | +$425K |
|
3043
MainStreet Bancshares
MNSB
$176M
| $412K | ﹤0.01% |
18,056
-2,444
| -12% | -$57.5K |
|
3044
Rivian
RIVN
$22.5B
| $411K | ﹤0.01% |
12,500
-1,903,200
| -99% | -$64.9M |
|
3045
Vanguard Morningstar Small-Cap Growth ETF
VBK
$25B
| $410K | ﹤0.01% |
2,100
-8,400
| -80% | -$1.8M |
|
|
VIRX
3046
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $409K | ﹤0.01% |
95,899
+2,500
| +3% | +$10.6K |
|
|
BNSO
3047
DELISTED
Bonso Electronic International
BNSO
| $408K | ﹤0.01% |
138,400
-7,500
| -5% | -$26.8K |
|
|
LX
3048
LexinFintech Holdings
LX
$221M
| $407K | ﹤0.01% |
240,600
+21,800
| +10% | +$43.9K |
|
|
ALR
3049
DELISTED
AlerisLife Inc
ALR
| $407K | ﹤0.01% |
428,500
-37,700
| -8% | -$43.3K |
|
3050
EuroDry
EDRY
$109M
| $406K | ﹤0.01% |
31,200
-6,500
| -17% | -$101K |
|
Similar funds
Jim Simons's Q3 2022 Portfolio in Review
As of Q3 2022, Jim Simons held 4,619 positions worth $70.7B, down 16% from $84.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons withdrew a net $8.71B in Q3 2022, closing 637 positions and reducing 2,164 holdings. Its most notable exit was Shopify, an estimated $439M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Alphabet (Google) Class A worth $498M.
- Jim Simons's largest Q3 2022 buy was Alphabet (Google) Class A: 5,208,460 shares worth $498M.
- Jim Simons added most to Advanced Micro Devices in Q3 2022, an estimated $404M increase.
- Jim Simons's biggest Q3 2022 reduction was Apple, cutting an estimated $777M.
- Jim Simons fully exited Shopify in Q3 2022, selling an estimated $439M.
- Jim Simons's ten largest holdings make up 11% of its $70.7B portfolio in Q3 2022.
- Jim Simons opened 441 new positions and closed 637 in Q3 2022.
- Jim Simons's portfolio value fell 16% quarter-over-quarter to $70.7B.
Based on Renaissance Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.